STRENGTHS AND LIMITATIONS OF FUNCTIONAL HEALTH STATUS INSTRUMENTS FOR OSTEOARTHRITIS

Author(s)

Kelleher JK1, Stephens JM2, Haider S3, Pashos CL1 , 1Abt Associates Clinical Trials, Cambridge, MA, USA; 2Abt Associates Clinical Trials, Bethesda, MD, USA; 3Pfizer, Inc, Groton, CT, USA

The number of people with arthritis in the US was 43 million in 1998, and is projected to reach 60 million by 2020. The burden of arthritis is substantial and is responsible for $65 billion annually in direct medical costs and lost productivity. The most common form of arthritis, osteoarthritis (OA), currently affects over 20 million adults in the US. Because OA has no known cure, the goals of therapy are symptom relief and improvement in patient-reported outcomes. OBJECTIVES: Our objective was to systematically review disease-specific functional health status instruments recommended in consensus guidelines for clinical research in OA (as established by Outcome Measures in Rheumatoid Arthritis Clinical Trials (OMERACT) and OsteoArthritis Research Society International (OARSI)) and to assess their ability to predict economic outcomes. METHODS: Computerized literature searches were conducted in the following databases from 1978-2002: EMBASE, HealthSTAR, MEDLINE, and PSYCHINFO. Manual searches were also conducted. The six disease-specific instruments recommended by the OMERACT/OARSI guidelines were reviewed with regard to their domains, psychometric properties, and usefulness in clinical research: the Health Assessment Questionnaire, Arthritis Impact Measurement Scales, Western Ontario and McMaster Universities Arthritis Index, Indices of Clinical Severity, Australian/Canadian Osteoarthritis Hand Index, and the Algofunctional Index. RESULTS: Substantial variation in the psychometric properties and domains covered by the instruments was found. Physical function and pain were the domains which were most frequently emphasized and which seemed to have the most value in predicting economic burden of disease. Underrepresented areas included the mental, social and emotional aspects of OA. CONCLUSIONS: Additional research should evaluate the usefulness of various instruments in assessing the impact of OA treatments through change in physical and psychological health status over the long term. Further evaluation of instruments' predictability of economic outcomes is needed.

Conference/Value in Health Info

2002-05, ISPOR 2002, Arlington, VA, USA

Value in Health, Vol. 5, No. 3 (May/June 2002)

Code

PAO17

Topic

Patient-Centered Research

Topic Subcategory

Patient-reported Outcomes & Quality of Life Outcomes

Disease

Musculoskeletal Disorders

Explore Related HEOR by Topic


Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×